Inhaled cromoglycate versus nedocromil: clinical results
1994

Inhaled Cromoglycate vs Nedocromil: Clinical Results

Sample size: 16 publication Evidence: moderate

Author Information

Author(s): L. Armenio, L. Brunetti, D. Colazzo, F. Cardinale

Primary Institution: Istituto di Pediatria Clinica e Sociale, Università di Bari

Hypothesis

Is nedocromil more effective than sodium cromoglycate in treating asthma?

Conclusion

Nedocromil sodium is effective in improving lung function and reducing asthma symptoms in children.

Supporting Evidence

  • Nedocromil improved spirometric data and bronchial hyper-reactivity in asthmatic patients.
  • The study involved a comparison of nedocromil and sodium cromoglycate in treating asthma.

Takeaway

This study shows that nedocromil can help kids with asthma breathe better.

Methodology

The study evaluated 16 patients with asthma and cystic fibrosis before and after 2 months of therapy with nedocromil.

Limitations

The therapeutic benefits in cystic fibrosis patients were less evident due to various influencing factors.

Participant Demographics

10 patients with asthma and 6 with cystic fibrosis, aged 9.2 years on average.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication